CONTEMP-ICD
Comparative Effectiveness of Prophylactic ICD Versus Non-ICD Therapy in Contemporary Heart Failure Patients with a Low Risk for Arrhythmic Death
Principal Investigator(s): Dan L. Musat, MD
Status: Open and enrolling
To view the clinical trials Valley currently has available, please use the search field or select a clinical specialty from the drop-down list below. Be sure to check back frequently, as we are always adding new studies.
For more information about any of our clinical trials, please email [email protected] or call 201-447-8453. (For cancer clinical trials, please call 201-634-5792.)
Comparative Effectiveness of Prophylactic ICD Versus Non-ICD Therapy in Contemporary Heart Failure Patients with a Low Risk for Arrhythmic Death
Principal Investigator(s): Dan L. Musat, MD
Status: Open and enrolling
His Bundle Corrective Pacing in Heart Failure (HIS-CRT)
Principal Investigator(s): Suneet Mittal, MD
Status: Open and enrolling
Cardiac Resynchronization Therapy Using His/Left Bundle Branch Pacing vs Biventricular Pacing With a Left Ventricular Epicardial Lead in Patients With Heart Failure (HF) With Left Ventricular Ejection Fraction (LVEF)≤50% and With Either a Wide QRS Complex (>130 ms) or With/Anticipated >40% Pacing Randomized Clinical Trial
Principal Investigator(s): Suneet Mittal, MD
Status: Open and enrolling
A Prospective, Multi-center, Non-randomized, Single Arm Open Label Study of 620 Subjects Receiving the OPTIMIZER Smart With CCM Therapy as Standard of Care
Principal Investigator(s): Suneet Mittal, MD
Status: Open and enrolling
PULSED AF Post-Approval Study, an Addendum to the PulseSelect™ PFA Global Registry
Principal Investigator(s): Suneet Mittal, MD
Status: Open and enrolling
REACT-AF: The Rhythm Evaluation for AntiCoagulaTion with Continuous Monitoring of Atrial Fibrillation
Principal Investigator(s): Suneet Mittal, MD
Status: Open and enrolling
WATCHMAN FLX™ Pro Left Atrial Appendage Closure Device With Alternative Post-Implant Monotherapy
Principal Investigator(s): Suneet Mittal, MD
Status: Open and enrolling
Posterior Wall Substrate Modification Using Irreversible Electroporation for the Treatment of Paroxysmal Atrial Fibrillation
Principal Investigator(s): Mohammadali Habibi, MD
Status: Open and enrolling